<DOC>
	<DOCNO>NCT02501265</DOCNO>
	<brief_summary>This study design test adaptive pharmacotherapy algorithm within Duke Smoking Cessation Program ( DSCP ) . The investigator hypothesize patient treat DSCP Algorithm-based pharmacotherapy vs. Varenicline show significantly high 12-week post-quit 30-day continuous abstinence .</brief_summary>
	<brief_title>Adaptive Pharmacotherapy Tobacco Dependence</brief_title>
	<detailed_description>This research study cross-randomized , placebo-controlled trial evaluate algorithm-based pharmacotherapy approach treat tobacco use ( 'Algorithm ' ) efficacy high intensity behavioral treatment comparison standard care . The Algorithm design assist clinician identify appropriate pharmacotherapy behavioral intervention treat tobacco use provide additional medication individual decrease tobacco use follow two week pre-quit pharmacotherapy ( 'Non-Responders ' ) . The population group recruit patient see Duke Smoking Cessation Program . Outcomes abstinence variable analyze use general regression model use ANOVA-based design ; randomization status pharmacotherapy behavioral group denote use proxy variable test primary study effect . An alpha criterion 0.05 ( two-tailed ) use comparison . Risk study low pharmacotherapies evaluate FDA-approved tobacco use treatment .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Participants screen treated Translational Smoking Cessation Program ( TSCP ) . Practically speak , however , TSCP treat patient selfreported smoker , 18 year age old , would like quit smoking . 1 . Patient treat DSCP tobacco use 2 . Age 18 year old 3 . Actively smoke 5 cigarette per day least one year 4 . Fluency speak write English 5 . Willing set quit date within 6 week 6 . Access telephone 7 . Willingness attend 7 week ( 24 hour ) group therapy specific offer date . 8 . Willingness take Varenicline , Bupropion Nicotine Patch . 1 . CO test 7 ppm 2 . 8 Alcohol Use Disorders Identification Test ( AUDIT10 ) 3 . 6 Drug Abuse Screening Test ( DAST10 ) 4 . 3 Patient Health Questionnaire ( PHQ2 ) Depression Scale 5 . Daily use second form tobacco nicotine ( e.g . ecigarettes , cigar , chew tobacco , snuff ) 6 . Current use smoking cessation medication ( e.g . nicotine replacement , Varenicline , Bupropion ) 7 . Intolerable side effect relate , refusal take , medical contraindication use Varenicline , nicotine patch , Bupropion . 8 . Symptomatic cognitive emotive disorder untreated schizophrenia , severe untreated depression , anxiety . This determined clinical assessment . 9 . Disruptive behavior toward staff . Because subject request engage group behavioral treatment , criterion protection participant within group treatment . 10 . Report pregnancy , attempt get pregnant , actively breast feed . 11 . Positive urine pregnancy test ( give female child bear potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Nicotine addiction</keyword>
	<keyword>Cigarette smoking</keyword>
</DOC>